Did You Know?

Editor’s Picks

Latest News

Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)

Full year fiscal 2025 net revenue of $66.4 millionFull year fiscal 2025 net loss of $13.6 millionFull year fiscal 2025...

Hemostemix Files FDA Submission for Basket Protocol (Filing 1517) to Advance ACP-01 (VesCell(TM)) Across Multiple Ischemic and Vascular Indications Simultaneously

Calgary, Alberta--(Newsfile Corp. - September 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...

IMPLANET Signs Exclusive Distribution Agreement with TINAVI Medical Technologies for the TiRobot® Spine Surgery System

Strengthening the commercialization strategy for cobotic1 solutions in orthopedic surgeryBORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168,...

IMPLANET Signs Exclusive Distribution Agreement with TINAVI Medical Technologies for the TiRobot® Spine Surgery System

Strengthening the commercialization strategy for cobotic1 solutions in orthopedic surgeryBORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168,...

error: Content is protected !!